Sernova Corp. (SVA.TO)

CAD 0.2

(8.11%)

Long Term Debt Summary of Sernova Corp.

  • Sernova Corp.'s latest annual long term debt in 2023 was - CAD , down -100.0% from previous year.
  • Sernova Corp.'s latest quarterly long term debt in 2024 Q1 was 546.46 Thousand CAD , down 0.0% from previous quarter.
  • Sernova Corp. reported annual long term debt of 136.12 Thousand CAD in 2022, down -50.68% from previous year.
  • Sernova Corp. reported annual long term debt of 275.97 Thousand CAD in 2021, down -60.72% from previous year.
  • Sernova Corp. reported quarterly long term debt of 521.34 Thousand CAD for 2024 Q2, down 0.0% from previous quarter.
  • Sernova Corp. reported quarterly long term debt of 495.35 Thousand CAD for 2024 Q3, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Sernova Corp. (2023 - 1999)

Historical Annual Long Term Debt of Sernova Corp. (2023 - 1999)

Year Long Term Debt Long Term Debt Growth
2023 - CAD -100.0%
2022 136.12 Thousand CAD -50.68%
2021 275.97 Thousand CAD -60.72%
2020 702.61 Thousand CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2015 - CAD 0.0%
2014 - CAD 0.0%
2013 - CAD 0.0%
2012 - CAD 0.0%
2011 - CAD 0.0%
2010 - CAD 0.0%
2009 - CAD 0.0%
2008 - CAD 0.0%
2007 - CAD 0.0%
2006 - CAD 0.0%
2005 - CAD 0.0%
2004 - CAD 0.0%
2003 - CAD 0.0%
2002 - CAD 0.0%
2001 - CAD 0.0%
2000 - CAD 0.0%
1999 - CAD 0.0%

Peer Long Term Debt Comparison of Sernova Corp.

Name Long Term Debt Long Term Debt Difference
Appili Therapeutics Inc. 875.2 Thousand CAD 100.0%
Eupraxia Pharmaceuticals Inc. - CAD NaN%
Helix BioPharma Corp. - CAD NaN%
Microbix Biosystems Inc. 6.37 Million CAD 100.0%
Medicenna Therapeutics Corp. - CAD NaN%
Satellos Bioscience Inc. - CAD NaN%
Oncolytics Biotech Inc. 290 Thousand CAD 100.0%